๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tyrosine Kinase Inhibitors and Anti-Angiogenic Therapies in Kidney Cancer

โœ Scribed by Naomi B. Haas; Robert G. Uzzo

Book ID
107531993
Publisher
Springer
Year
2007
Tongue
English
Weight
271 KB
Volume
8
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tyrosine kinase inhibitors in cancer the
Tyrosine kinase inhibitors in cancer therapy
โœ Srinivasan Madhusudan; Trivadi S. Ganesan ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 518 KB
Tyrosine kinase inhibitors as antiprolif
Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro
โœ Twaddle, George M.; Turbov, Jane; Liu, Naxin; Murthy, Satya ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 142 KB

Background and Objectives: Receptor tyrosine kinase (RTK) activation is critical for growth factor-mediated cell proliferation. Blockade of RTK activation inhibits growth factor-induced cell proliferation. A panel of RTK inhibitors (tyrphostins) have been tested and compared for their antiproliferat